Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.
Clinical trial NCT02273167 · COMPLETED
Trial details
- NCT number
- NCT02273167
- Sponsor
- Norgine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-08-01
- Enrollment
- 849
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.